PL1744733T3 - Kompozycje farmaceutyczne zamknięte w miękkich kapsułkach żelowych zawierające stężone składniki czynne - Google Patents

Kompozycje farmaceutyczne zamknięte w miękkich kapsułkach żelowych zawierające stężone składniki czynne

Info

Publication number
PL1744733T3
PL1744733T3 PL05745455T PL05745455T PL1744733T3 PL 1744733 T3 PL1744733 T3 PL 1744733T3 PL 05745455 T PL05745455 T PL 05745455T PL 05745455 T PL05745455 T PL 05745455T PL 1744733 T3 PL1744733 T3 PL 1744733T3
Authority
PL
Poland
Prior art keywords
softgel
pharmaceutical compositions
active ingredients
concentrated active
encapsulated pharmaceutical
Prior art date
Application number
PL05745455T
Other languages
English (en)
Inventor
Jayant Ekanth Khanolkar
Shane Michael De La Harpe
Original Assignee
The Procter And Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter And Gamble Company filed Critical The Procter And Gamble Company
Publication of PL1744733T3 publication Critical patent/PL1744733T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05745455T 2004-05-06 2005-05-05 Kompozycje farmaceutyczne zamknięte w miękkich kapsułkach żelowych zawierające stężone składniki czynne PL1744733T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/840,143 US20050249802A1 (en) 2004-05-06 2004-05-06 Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
EP05745455.5A EP1744733B1 (en) 2004-05-06 2005-05-05 Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
PCT/US2005/015746 WO2005107709A2 (en) 2004-05-06 2005-05-05 Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients

Publications (1)

Publication Number Publication Date
PL1744733T3 true PL1744733T3 (pl) 2019-02-28

Family

ID=35239693

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05745455T PL1744733T3 (pl) 2004-05-06 2005-05-05 Kompozycje farmaceutyczne zamknięte w miękkich kapsułkach żelowych zawierające stężone składniki czynne

Country Status (11)

Country Link
US (1) US20050249802A1 (pl)
EP (1) EP1744733B1 (pl)
JP (1) JP2007536257A (pl)
CN (1) CN1980646B (pl)
AU (1) AU2005240187B2 (pl)
BR (1) BRPI0510694A (pl)
CA (1) CA2565252C (pl)
ES (1) ES2699711T3 (pl)
MX (1) MXPA06012738A (pl)
PL (1) PL1744733T3 (pl)
WO (1) WO2005107709A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
KR20090088913A (ko) 2006-11-21 2009-08-20 맥네일-피피씨, 인코포레이티드 개질된 방출형 진통 현탁제
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
JP5503939B2 (ja) * 2009-10-16 2014-05-28 東洋カプセル株式会社 アゼラスチン塩酸塩含有カプセル剤
PL3515413T3 (pl) 2016-09-26 2023-11-13 The Procter & Gamble Company Postać dawkowania zapewniająca przedłużoną ulgę
CA3100314A1 (en) 2018-05-16 2019-11-21 Bayer Healthcare Llc High concentration suspension formulation for cold and flu soft gel capsule medications
EP3952900A1 (en) 2019-04-11 2022-02-16 R.P. Scherer Technologies, LLC Formulation for oral delivery of proteins, peptides and small molecules with poor permeability
CN113398274B (zh) * 2021-06-11 2022-05-31 包头东宝生物技术股份有限公司 提升明胶溶解性能的方法和该方法制备的高溶解性明胶

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002777A (en) * 1986-06-24 1991-03-26 Norcliff Thayer Inc. Encapsulated antacid
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
NZ280610A (en) * 1994-12-29 1997-08-22 Mcneil Ppc Inc Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
CA2223768A1 (en) * 1995-06-09 1996-12-27 R.P. Scherer Corporation Suspension and soft gelatin capsules containing particulate matter
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US5908636A (en) * 1996-06-28 1999-06-01 Mcneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
EP0946145B1 (en) * 1996-12-20 2008-09-03 McNeil-PPC, Inc. Antitussive drugs delivered by ion exchange resins
US6197787B1 (en) * 1997-03-03 2001-03-06 Sanofi-Synthelabo Pharmaceutical formulations containing poorly soluble drug substances
US6383515B2 (en) * 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
CZ2002947A3 (cs) * 1999-09-29 2002-08-14 The Procter & Gamble Company Kapalný prostředek, nejlépe orální prostředek se zlepąenou stabilitou a způsob přípravy
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
US7138133B2 (en) * 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions

Also Published As

Publication number Publication date
AU2005240187A1 (en) 2005-11-17
CA2565252A1 (en) 2005-11-17
ES2699711T3 (es) 2019-02-12
WO2005107709A2 (en) 2005-11-17
CN1980646B (zh) 2010-05-26
CN1980646A (zh) 2007-06-13
US20050249802A1 (en) 2005-11-10
AU2005240187B2 (en) 2009-07-02
WO2005107709A3 (en) 2006-12-07
EP1744733B1 (en) 2018-09-19
BRPI0510694A (pt) 2007-12-26
CA2565252C (en) 2010-04-13
JP2007536257A (ja) 2007-12-13
MXPA06012738A (es) 2007-01-16
EP1744733A2 (en) 2007-01-24

Similar Documents

Publication Publication Date Title
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
EP1631239A4 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE COMPOUNDS OF VITAMIN D
PL1940249T3 (pl) Nowe formulacje rozpuszczalnych w tłuszczach składników aktywnych o wysokiej biodostępności
PL1981915T3 (pl) Kompozycje składników aktywnych
EP2039366A4 (en) COMPOSITION CONTAINING PEPTIDE AS ACTIVE INGREDIENT
HUE039142T2 (hu) Fungicid hatóanyag-kombinációk
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
ZA200701557B (en) Pharmaceutical compositions comprising diclofenac
IL223545A0 (en) Pharmaceutical compositions
IL179809A0 (en) Pharmaceutical compositions
GB0408308D0 (en) Pharmaceutical compositions
IL188744A0 (en) High drug load formulations and dosage forms
IL206364A0 (en) Pharmaceutical compositions containing at least one protein active ingredient protected from digestive enzymes
IL186805A0 (en) Pharmaceutical compositions containing an active vitamin d compound
PL1837019T3 (pl) Kompozycja farmaceutyczna rozpadająca się w ustach
PL1744733T3 (pl) Kompozycje farmaceutyczne zamknięte w miękkich kapsułkach żelowych zawierające stężone składniki czynne
IL178067A0 (en) Pharmaceutical dosage forms and compositions
EP1805154A4 (en) PHARMACEUTICAL COMPOSITIONS
IL179697A0 (en) Variants of unc5h2, their preparation and pharmaceutical compositions containing them
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
IL172304A0 (en) Pharmaceutical compositions comprising active vitamin d compounds
GB0407351D0 (en) Pharmaceutical compositions
IL178928A0 (en) Pharmaceutical compositions comprising zd6474
GB0400971D0 (en) Pharmaceutical compositions
GB0422582D0 (en) Pharmaceutical compositions